Epilepsy, Partial Seizures
4 clinical trials · Condition
◉ Watch Epilepsy, Partial Seizures
| Record | Firm | Date |
|---|---|---|
| A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures (NCT01463306) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2012-02-21 |
| A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years (NCT01389596) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-09-27 |
| Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures (NCT00275912) | Novartis | 2006-09-11 |
| Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures (NCT00275925) | Novartis | 2005-12-01 |
Track Epilepsy, Partial Seizures automatically
Every clearance here is in the API, with alerts when new ones post.